“Hepatitis b”的搜索结果，显示 251-260 项，共有 9261 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

2. 肝细胞癌（HCC） - 医生与科室- 妙佑医疗国际

   ... Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease..., Ascites, Portal hypertension, Alcoholic hepatitis. 显示更多擅长领域 针对Hugo E. Vargas, M.D. ...

3. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. 血液科- 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

6. Mayo Clinic Neurosciences Physician Update — September 2025

   Page 1.

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) As Monotherapy And In Combination, For Treatment Of Patients With Indolent Non-Hodgkin Lymphoma.

9. 血液科- 临床试验- 妙佑医疗国际

   ... B-cell lymphoma 2 (BCL2) inhibitor. Sacituzumab Tirumotecan (MK-2870) In Combination With Pembrolizumab Versus Pembrolizumab Alone In Metastatic Non-small ...

10. 血液科- 临床试验- 妙佑医疗国际

    Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia. Rochester, Minn. This ...